Infectious Disease· Topic 7.17 Specific causative organisms· 7.17.6

Herpes simplex virus (HSV) infection

Herpes simplex virus type 1 or 2 establishes lifelong latency in sensory ganglia after mucocutaneous infection, causing painful vesicular-to-ulcerative outbreaks of the mouth or genitals with intermittent asymptomatic shedding; diagnosis is by NAAT of an ulcer swab and treatment is oral nucleoside analogues, escalating to intravenous acyclovir for encephalitis, severe mucocutaneous disease, or disseminated infection in immunosuppressed hosts.

14 min read14 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    A lifelong, incurable infection with two overlapping clinical patterns: herpes simplex virus type 1 (HSV-1) is transmitted by oral-oral or oral-genital contact and classically causes orolabial…

  • Epidemiology

    HSV-1 affects approximately 48% of adults, acquired earlier in life through nonsexual oral contact in childhood or adolescence.

  • Risk factors

    Direct mucocutaneous or oral contact with an infected partner during a symptomatic outbreak or asymptomatic shedding is the dominant risk factor for acquisition.

  • Pathophysiology

    Initial mucocutaneous inoculation produces local viral replication in epithelial cells, generating the classic vesicle-to-ulcer lesion sequence over 2 to 3 weeks in primary infection.

  • Clinical features

    Primary genital or oral infection presents with multiple painful lesions that progress from erythematous papules to vesicles, then ulcerate, crust, and heal over 2 to 3 weeks, often accompanied by…

  • Differential diagnosis

    Primary syphilis (chancre): a single painless, indurated ulcer with a raised regular border and nontender regional lymphadenopathy, unlike the multiple painful HSV vesicles/ulcers; confirm with…

  • Diagnosis

    First, for any symptomatic outbreak, HSV mucocutaneous infection is confirmed by obtaining a swab from an unroofed vesicle or the base of the ulcer and sending nucleic acid amplification testing…

  • Management

    For primary genital or first-episode infection, start oral antiviral therapy as soon as the diagnosis is suspected, before laboratory confirmation returns, because early treatment shortens time to…

  • Complications

    HSV encephalitis with seizures, focal deficits, and a high risk of death or severe neurologic sequelae without prompt intravenous acyclovir; older age, abnormal Glasgow Coma Scale score, and delayed…

  • Prognosis

    Primary mucocutaneous outbreaks resolve within 2 to 3 weeks even without treatment; antiviral therapy shortens this course but does not eradicate latent infection.

  • Prevention

    Offer suppressive antiviral therapy (valacyclovir 500 mg to 1 g PO once daily, famciclovir 250 mg PO twice daily, or acyclovir 400 mg PO twice daily, continued indefinitely with annual review) to…

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.